In India, the developers have tied up with Dr Reddy’s Laboratories for trials and regulatory approvals and, if approved, RDIF will supply 100 million doses of the vaccine to Dr Reddy’s for distribution
from Hindustan Times - india https://ift.tt/3oWcVmj
No comments:
Post a Comment